Go Pro
→ Your book is inside (From Profits Run) (Ad)tc pixel Free NUS Stock Alerts

Nu Skin Enterprises (NUS) Competitors

Nu Skin Enterprises logo
$5.27 +0.04 (+0.82%)
Closing price 07/13/2026 03:59 PM Eastern
Extended Trading
$5.26 -0.01 (-0.25%)
As of 07/13/2026 07:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

NUS vs. COTY, USNA, NATR, MED, and VERU

Should you buy Nu Skin Enterprises stock or one of its competitors? MarketBeat compares Nu Skin Enterprises with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Nu Skin Enterprises include Coty (COTY), USANA Health Sciences (USNA), Nature's Sunshine Products (NATR), Medifast (MED), and Veru (VERU).

How does Nu Skin Enterprises compare to Coty?

Coty (NYSE:COTY) and Nu Skin Enterprises (NYSE:NUS) are both small-cap consumer staples companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, profitability, analyst recommendations, dividends, media sentiment, risk, valuation and institutional ownership.

In the previous week, Coty had 14 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 14 mentions for Coty and 0 mentions for Nu Skin Enterprises. Coty's average media sentiment score of 0.73 beat Nu Skin Enterprises' score of 0.00 indicating that Coty is being referred to more favorably in the media.

Company Overall Sentiment
Coty Positive
Nu Skin Enterprises Neutral

42.4% of Coty shares are held by institutional investors. Comparatively, 82.8% of Nu Skin Enterprises shares are held by institutional investors. 5.9% of Coty shares are held by company insiders. Comparatively, 2.8% of Nu Skin Enterprises shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Coty currently has a consensus price target of $3.70, suggesting a potential upside of 66.45%. Given Coty's stronger consensus rating and higher probable upside, research analysts plainly believe Coty is more favorable than Nu Skin Enterprises.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Coty
3 Sell rating(s)
13 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.88
Nu Skin Enterprises
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Nu Skin Enterprises has a net margin of 3.78% compared to Coty's net margin of -9.20%. Nu Skin Enterprises' return on equity of 7.47% beat Coty's return on equity.

Company Net Margins Return on Equity Return on Assets
Coty-9.20% 4.59% 1.47%
Nu Skin Enterprises 3.78%7.47%4.21%

Coty has a beta of 0.99, suggesting that its stock price is 1% less volatile than the broader market. Comparatively, Nu Skin Enterprises has a beta of 0.97, suggesting that its stock price is 3% less volatile than the broader market.

Nu Skin Enterprises has lower revenue, but higher earnings than Coty. Coty is trading at a lower price-to-earnings ratio than Nu Skin Enterprises, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Coty$5.79B0.34-$367.90M-$0.62N/A
Nu Skin Enterprises$1.49B0.17$160.20M$1.104.79

Coty pays an annual dividend of $0.50 per share and has a dividend yield of 22.5%. Nu Skin Enterprises pays an annual dividend of $0.24 per share and has a dividend yield of 4.6%. Coty pays out -80.6% of its earnings in the form of a dividend. Nu Skin Enterprises pays out 21.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Coty is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

Coty beats Nu Skin Enterprises on 11 of the 18 factors compared between the two stocks.

How does Nu Skin Enterprises compare to USANA Health Sciences?

USANA Health Sciences (NYSE:USNA) and Nu Skin Enterprises (NYSE:NUS) are both small-cap personal products companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, media sentiment, profitability, analyst recommendations, risk, institutional ownership and dividends.

In the previous week, USANA Health Sciences had 2 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 2 mentions for USANA Health Sciences and 0 mentions for Nu Skin Enterprises. USANA Health Sciences' average media sentiment score of 0.55 beat Nu Skin Enterprises' score of 0.00 indicating that USANA Health Sciences is being referred to more favorably in the media.

Company Overall Sentiment
USANA Health Sciences Positive
Nu Skin Enterprises Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
USANA Health Sciences
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Nu Skin Enterprises
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Nu Skin Enterprises has higher revenue and earnings than USANA Health Sciences. Nu Skin Enterprises is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
USANA Health Sciences$925.26M0.44$10.76M$0.4746.96
Nu Skin Enterprises$1.49B0.17$160.20M$1.104.79

Nu Skin Enterprises has a net margin of 3.78% compared to USANA Health Sciences' net margin of 0.96%. Nu Skin Enterprises' return on equity of 7.47% beat USANA Health Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
USANA Health Sciences0.96% 6.21% 4.50%
Nu Skin Enterprises 3.78%7.47%4.21%

USANA Health Sciences has a beta of 0.73, suggesting that its stock price is 27% less volatile than the broader market. Comparatively, Nu Skin Enterprises has a beta of 0.97, suggesting that its stock price is 3% less volatile than the broader market.

54.3% of USANA Health Sciences shares are held by institutional investors. Comparatively, 82.8% of Nu Skin Enterprises shares are held by institutional investors. 0.8% of USANA Health Sciences shares are held by insiders. Comparatively, 2.8% of Nu Skin Enterprises shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Nu Skin Enterprises beats USANA Health Sciences on 8 of the 13 factors compared between the two stocks.

How does Nu Skin Enterprises compare to Nature's Sunshine Products?

Nu Skin Enterprises (NYSE:NUS) and Nature's Sunshine Products (NASDAQ:NATR) are both small-cap personal products companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership, profitability and media sentiment.

Nu Skin Enterprises has a beta of 0.97, suggesting that its stock price is 3% less volatile than the broader market. Comparatively, Nature's Sunshine Products has a beta of 0.87, suggesting that its stock price is 13% less volatile than the broader market.

82.8% of Nu Skin Enterprises shares are owned by institutional investors. Comparatively, 79.4% of Nature's Sunshine Products shares are owned by institutional investors. 2.8% of Nu Skin Enterprises shares are owned by company insiders. Comparatively, 3.1% of Nature's Sunshine Products shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Nature's Sunshine Products has a consensus price target of $35.00, indicating a potential upside of 62.19%. Given Nature's Sunshine Products' stronger consensus rating and higher possible upside, analysts plainly believe Nature's Sunshine Products is more favorable than Nu Skin Enterprises.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nu Skin Enterprises
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Nature's Sunshine Products
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.00

Nature's Sunshine Products has a net margin of 4.06% compared to Nu Skin Enterprises' net margin of 3.78%. Nature's Sunshine Products' return on equity of 14.67% beat Nu Skin Enterprises' return on equity.

Company Net Margins Return on Equity Return on Assets
Nu Skin Enterprises3.78% 7.47% 4.21%
Nature's Sunshine Products 4.06%14.67%9.27%

Nu Skin Enterprises has higher revenue and earnings than Nature's Sunshine Products. Nu Skin Enterprises is trading at a lower price-to-earnings ratio than Nature's Sunshine Products, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nu Skin Enterprises$1.49B0.17$160.20M$1.104.79
Nature's Sunshine Products$480.14M0.79$19.52M$1.1019.62

In the previous week, Nature's Sunshine Products had 2 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 2 mentions for Nature's Sunshine Products and 0 mentions for Nu Skin Enterprises. Nature's Sunshine Products' average media sentiment score of 1.95 beat Nu Skin Enterprises' score of 0.00 indicating that Nature's Sunshine Products is being referred to more favorably in the news media.

Company Overall Sentiment
Nu Skin Enterprises Neutral
Nature's Sunshine Products Very Positive

Summary

Nature's Sunshine Products beats Nu Skin Enterprises on 12 of the 16 factors compared between the two stocks.

How does Nu Skin Enterprises compare to Medifast?

Medifast (NYSE:MED) and Nu Skin Enterprises (NYSE:NUS) are both small-cap consumer staples companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, analyst recommendations, institutional ownership, media sentiment, risk and valuation.

Medifast presently has a consensus target price of $12.00, indicating a potential upside of 8.95%. Given Medifast's higher probable upside, research analysts plainly believe Medifast is more favorable than Nu Skin Enterprises.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Medifast
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Nu Skin Enterprises
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

In the previous week, Medifast's average media sentiment score of 0.00 equaled Nu Skin Enterprises'average media sentiment score.

Company Overall Sentiment
Medifast Neutral
Nu Skin Enterprises Neutral

Medifast has a beta of 0.65, indicating that its stock price is 35% less volatile than the broader market. Comparatively, Nu Skin Enterprises has a beta of 0.97, indicating that its stock price is 3% less volatile than the broader market.

Nu Skin Enterprises has a net margin of 3.78% compared to Medifast's net margin of -5.78%. Nu Skin Enterprises' return on equity of 7.47% beat Medifast's return on equity.

Company Net Margins Return on Equity Return on Assets
Medifast-5.78% -4.80% -3.83%
Nu Skin Enterprises 3.78%7.47%4.21%

95.5% of Medifast shares are held by institutional investors. Comparatively, 82.8% of Nu Skin Enterprises shares are held by institutional investors. 3.7% of Medifast shares are held by company insiders. Comparatively, 2.8% of Nu Skin Enterprises shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Nu Skin Enterprises has higher revenue and earnings than Medifast. Medifast is trading at a lower price-to-earnings ratio than Nu Skin Enterprises, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medifast$385.79M0.32-$18.67M-$1.83N/A
Nu Skin Enterprises$1.49B0.17$160.20M$1.104.79

Summary

Nu Skin Enterprises beats Medifast on 8 of the 12 factors compared between the two stocks.

How does Nu Skin Enterprises compare to Veru?

Nu Skin Enterprises (NYSE:NUS) and Veru (NASDAQ:VERU) are both small-cap personal products companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and dividends.

82.8% of Nu Skin Enterprises shares are owned by institutional investors. Comparatively, 47.2% of Veru shares are owned by institutional investors. 2.8% of Nu Skin Enterprises shares are owned by company insiders. Comparatively, 14.2% of Veru shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Nu Skin Enterprises has a net margin of 3.78% compared to Veru's net margin of 0.00%. Nu Skin Enterprises' return on equity of 7.47% beat Veru's return on equity.

Company Net Margins Return on Equity Return on Assets
Nu Skin Enterprises3.78% 7.47% 4.21%
Veru N/A -54.72%-39.09%

Nu Skin Enterprises has a beta of 0.97, meaning that its share price is 3% less volatile than the broader market. Comparatively, Veru has a beta of -1.19, meaning that its share price is 219% less volatile than the broader market.

Veru has a consensus price target of $23.00, suggesting a potential upside of 798.44%. Given Veru's stronger consensus rating and higher possible upside, analysts plainly believe Veru is more favorable than Nu Skin Enterprises.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nu Skin Enterprises
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Veru
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

Nu Skin Enterprises has higher revenue and earnings than Veru. Veru is trading at a lower price-to-earnings ratio than Nu Skin Enterprises, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nu Skin Enterprises$1.49B0.17$160.20M$1.104.79
VeruN/AN/A-$22.73M-$0.89N/A

In the previous week, Veru had 3 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 3 mentions for Veru and 0 mentions for Nu Skin Enterprises. Veru's average media sentiment score of 0.63 beat Nu Skin Enterprises' score of 0.00 indicating that Veru is being referred to more favorably in the news media.

Company Overall Sentiment
Nu Skin Enterprises Neutral
Veru Positive

Summary

Nu Skin Enterprises beats Veru on 9 of the 15 factors compared between the two stocks.

Get Nu Skin Enterprises News Delivered to You Automatically

Sign up to receive the latest news and ratings for NUS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NUS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NUS vs. The Competition

Export
MetricNu Skin EnterprisesCOSMETICS&TLTRS IndustryStaples SectorNYSE Exchange
Market Cap$253.92M$3.09B$16.39B$23.46B
Dividend Yield4.59%5.03%3.33%4.02%
P/E Ratio4.7927.8126.3931.08
Price / Sales0.1719.3044.2019.77
Price / Cash2.1713.9113.3718.64
Price / Book0.325.995.984.77
Net Income$160.20M-$188.65M$668.93M$1.06B
7 Day Performance1.70%-1.53%-1.50%-0.23%
1 Month Performance-3.51%-3.90%-2.46%-0.11%
1 Year Performance-39.15%-29.82%-13.17%16.46%

Nu Skin Enterprises Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NUS
Nu Skin Enterprises
2.5188 of 5 stars		$5.27
+0.8%		N/A-43.1%$253.92M$1.49B4.792,800
COTY
Coty
4.4695 of 5 stars		$2.26
-1.7%		$3.70
+63.9%		-56.1%$2.03B$5.89BN/A11,636
USNA
USANA Health Sciences
2.13 of 5 stars		$21.82
+1.4%		N/A-33.1%$397.14M$925.26M46.431,570
NATR
Nature's Sunshine Products
3.4732 of 5 stars		$21.67
+0.9%		$35.00
+61.5%		+38.2%$377.55M$480.14M19.70850
MED
Medifast
1.8083 of 5 stars		$11.05
+0.8%		$12.00
+8.6%		-23.9%$121.87M$385.79MN/A870

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NYSE:NUS) was last updated on 7/14/2026 by MarketBeat.com Staff.
From Our Partners
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
When I found Rolls-Royce under $2, most people thought I was crazy
In 2022, Karim Rahemtulla recommended Rolls-Royce when it traded under $2. The stock climbed more than 1,100% ...
Monument Traders Alliance | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
Print this and keep it by your screen
Ever been right about a stock's direction and still lost money on the trade? It's almost never bad luck - it's...
Profits Run | Sponsoredtc pixel
Where to Put $100 Before Trump's New Tech Law Rolls Out
The Financial Times says a new tech law puts America 'on the verge of a financial revolution.' Yahoo Finance e...
Brownstone Research | Sponsoredtc pixel
The $5 company SpaceX can’t survive without
The investors who got rich on AI didn't all buy Nvidia. Some bought ASML, the company that makes the machines ...
Traders Agency | Sponsoredtc pixel
Trump Set to Unleash 219-Year-Old “Super Weapon” on U.S. Soil
Four-time U.S. Presidential advisor Jim Rickards is warning of a political move he calls 'The Trump Supremacy'...
Paradigm Press | Sponsoredtc pixel
Solar lost. Wind lost. One won.
Washington cut subsidies for solar, wind, and EVs - but one energy source had its tax credits fully preserved ...
Behind the Markets | Sponsoredtc pixel